Cargando…

New tumor-targeted nanosized delivery carrier for oligonucleotides: characteristics in vitro and in vivo

BACKGROUND: The purpose of this study was to investigate the in vitro and in vivo characteristics of a new tumor-targeted nanosized delivery carrier for antisense oligonucleotide (ASON). METHODS: Polyethylenimine (PEI) was used to condense ASON to form nanosized complexes (PEI/ASON), which were then...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tianyang, Jia, Xin, Li, Huixiang, Wang, Jin, Zhang, Hongling, A, Youmei, Zhang, Zhenzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152470/ https://www.ncbi.nlm.nih.gov/pubmed/21845042 http://dx.doi.org/10.2147/IJN.S15239

Ejemplares similares

Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
por: Boyuklieva, Radka, et al.
Publicado: (2022)

Preparation of Ru(ii)@oligonucleotide nanosized polymers as potential tumor-imaging luminescent probes
por: Yu, Geng-Nan, et al.
Publicado: (2018)

Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides
por: Shi, Yin-Feng, et al.
Publicado: (2011)

Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo
por: Wang, Mingxing, et al.
Publicado: (2020)

IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)

Charge density and particle size effects on oligonucleotide and plasmid DNA binding to nanosized hydrotalcite
por: Sanderson, Brian A, et al.
Publicado: (2013)

Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo
por: Yang, Liu, et al.
Publicado: (2020)

Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
por: Karavolos, Michail, et al.
Publicado: (2016)

Nanosized Drug Delivery Systems to Fight Tuberculosis
por: Bourguignon, Tom, et al.
Publicado: (2023)

Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023)

In vivo delivery of transcription factors with multifunctional oligonucleotides
por: Lee, Kunwoo, et al.
Publicado: (2015)

Recent advances in nanosized metal organic frameworks for drug delivery and tumor therapy
por: Yang, Junlei, et al.
Publicado: (2021)

Drug carriers based on highly protein-resistant materials for prolonged in vivo circulation time
por: Liu, Ruiyuan, et al.
Publicado: (2015)

Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis
por: Weiss, Lea, et al.
Publicado: (2023)

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
por: Lv, Li, et al.
Publicado: (2021)

The β-cyclodextrin-modified nanosized ZSM-5 zeolite as a carrier for curcumin
por: Amani, Shahin, et al.
Publicado: (2019)

Clindamycin-Loaded Nanosized Calcium Phosphates Powders as a Carrier of Active Substances
por: Słota, Dagmara, et al.
Publicado: (2023)

Amphipathic dendritic poly-peptides carrier to deliver antisense oligonucleotides against multi-drug resistant bacteria in vitro and in vivo
por: Chen, Zhou, et al.
Publicado: (2022)

Editorial: Nanosized Drug Delivery Systems: Colloids and Gels for Site Specific Targeting
por: Ehrbar, Martin, et al.
Publicado: (2020)

Correction: The β-cyclodextrin-modified nanosized ZSM-5 zeolite as a carrier for curcumin
por: Rahmani, Niloofar, et al.
Publicado: (2020)

Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
por: Kobayashi, Hisataka, et al.
Publicado: (2014)

Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems
por: Zhan, Cuiping, et al.
Publicado: (2023)

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides
por: Hammond, Suzan M, et al.
Publicado: (2014)

In vivo and in vitro studies of antisense oligonucleotides – a review
por: Kilanowska, Anna, et al.
Publicado: (2020)

Biocompatible PEO-b-PCL Nanosized Micelles as Drug Carriers: Structure and Drug–Polymer Interactions
por: Chroni, Angeliki, et al.
Publicado: (2020)

Delivery of therapeutic oligonucleotides in nanoscale
por: Wu, Lei, et al.
Publicado: (2021)

Visible-light-sensitive titanium dioxide nanoplatform for tumor-responsive Fe2+ liberating and artemisinin delivery
por: Zhang, Huijuan, et al.
Publicado: (2017)

The delivery of therapeutic oligonucleotides
por: Juliano, Rudolph L.
Publicado: (2016)

A nanosized anionic MOF with rich thiadiazole groups for controlled oral drug delivery
por: Jiang, Ke, et al.
Publicado: (2021)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
por: Järver, Peter, et al.
Publicado: (2012)

Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation
por: Omar, Mahmoud M, et al.
Publicado: (2019)

Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics
por: Tan, Qunyou, et al.
Publicado: (2013)

Synthesis, Self-Assembly and In Vitro Cellular Uptake Kinetics of Nanosized Drug Carriers Based on Aggregates of Amphiphilic Oligomers of N-Vinyl-2-pyrrolidone
por: Kulikov, Pavel P., et al.
Publicado: (2021)

Human β-Defensin 23 as a Carrier for In Vitro and In Vivo Delivery of mRNA
por: Kim, Kyoung-Ran, et al.
Publicado: (2023)

Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug
por: Brunetti, Jlenia, et al.
Publicado: (2015)

Multicellular Tumor Spheroids as a Model for Assessing Delivery of Oligonucleotides in Three Dimensions
por: Carver, Kyle, et al.
Publicado: (2014)

Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis
por: Cervadoro, Antonio, et al.
Publicado: (2018)

Liposome-coated lipoplex–based carrier for antisense oligonucleotides
por: Wyrozumska, Paulina, et al.
Publicado: (2014)

Design of Oligonucleotide Carriers: Importance of Polyamine Chain Length
por: Annenkov, Vadim V., et al.
Publicado: (2018)

Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice
por: Wang, Mingxing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d6b0b5pbt6fdti5u8q6ngafg5a